Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.7 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |